Literature DB >> 3855879

Premature sebaceous gland hyperplasia: successful treatment with isotretinoin.

C S Burton, W S Sawchuk.   

Abstract

Hyperplasia of sebaceous glands is a common cause of papulonodular facial lesions that occur in middle-aged and older patients. Recently, several cases of premature sebaceous gland hyperplasia have been reported. In these patients the lesions had persisted despite vigorous attempts at therapy. We present a case of premature sebaceous gland hyperplasia that was successfully treated with isotretinoin.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3855879     DOI: 10.1016/s0190-9622(85)80013-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  5 in total

Review 1.  Updated Physician's Guide to the Off-label Uses of Oral Isotretinoin.

Authors:  Steven Brandon Nickle; Nathan Peterson; Michael Peterson
Journal:  J Clin Aesthet Dermatol       Date:  2014-04

Review 2.  The retinoids. A review of their clinical pharmacology and therapeutic use.

Authors:  C E Orfanos; R Ehlert; H Gollnick
Journal:  Drugs       Date:  1987-10       Impact factor: 9.546

3.  Sebaceous hyperplasia effectively improved by the pin-hole technique with squeezing.

Authors:  Jae-Hong Kim; Hwa-Young Park; Won-Soo Lee; Jin-Soo Kang
Journal:  Ann Dermatol       Date:  2013-05-10       Impact factor: 1.444

4.  A Case of Cyclosporine-Induced Sebaceous Hyperplasia in a Renal Transplant Patient Successfully Treated with Isotretinoin.

Authors:  Hwa Young Jung; Miri Kim; Baik Kee Cho; Hyun Jeong Park
Journal:  Ann Dermatol       Date:  2016-03-31       Impact factor: 1.444

5.  Oral isotretinoin for the treatment of dermatologic conditions other than acne: a systematic review and discussion of future directions.

Authors:  Sherman Chu; Lauren Michelle; Chloe Ekelem; Calvin T Sung; Nathan Rojek; Natasha A Mesinkovska
Journal:  Arch Dermatol Res       Date:  2020-11-05       Impact factor: 3.017

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.